Australia, May 19 -- Neurocrine Biosciences Inc., owns the trademark (2626861) for 'AMPA PROGRAM' and 'MOLECULAR-DIAGRAM' till Jan. 6, 2036.
Status: protected:
Registered/protected
Classes: 42 [Pharmaceutical research and development services; conducting clinical trials for pharmaceutical preparations; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results; pharmaceutical research and development services in the field of anhedonia, major depressive disorder and mood disorders; conducting clinical trials for others for pharmaceutical preparations for the treatment and prevention of anhedoni...